nodes	percent_of_prediction	percent_of_DWPC	metapath
Tirofiban—ITGA2B—L1CAM interactions—CD24—multiple sclerosis	0.026	0.0348	CbGpPWpGaD
Tirofiban—ITGB3—L1CAM interactions—CD24—multiple sclerosis	0.02	0.0268	CbGpPWpGaD
Tirofiban—ITGB3—Osteoclast Signaling—IFNB1—multiple sclerosis	0.0199	0.0266	CbGpPWpGaD
Tirofiban—ITGA2B—Integrin family cell surface interactions—ITGA4—multiple sclerosis	0.0176	0.0236	CbGpPWpGaD
Tirofiban—ITGB3—Osteopontin Signaling—SPP1—multiple sclerosis	0.0168	0.0226	CbGpPWpGaD
Tirofiban—Cardiac tamponade—Methotrexate—multiple sclerosis	0.0165	0.0649	CcSEcCtD
Tirofiban—ITGB3—Cell surface interactions at the vascular wall—SELPLG—multiple sclerosis	0.0148	0.0198	CbGpPWpGaD
Tirofiban—ITGB3—Cell surface interactions at the vascular wall—MERTK—multiple sclerosis	0.0148	0.0198	CbGpPWpGaD
Tirofiban—ITGB3—Cell surface interactions at the vascular wall—CD58—multiple sclerosis	0.0148	0.0198	CbGpPWpGaD
Tirofiban—ITGB3—Osteoclast Signaling—SPP1—multiple sclerosis	0.0143	0.0191	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet degranulation—PLEK—multiple sclerosis	0.0141	0.0189	CbGpPWpGaD
Tirofiban—ITGB3—Integrin family cell surface interactions—ITGA4—multiple sclerosis	0.0136	0.0182	CbGpPWpGaD
Tirofiban—ITGA2B—Response to elevated platelet cytosolic Ca2+—PLEK—multiple sclerosis	0.0134	0.018	CbGpPWpGaD
Tirofiban—ITGB3—IL4-mediated signaling events—IL4R—multiple sclerosis	0.0133	0.0178	CbGpPWpGaD
Tirofiban—Haemorrhage intracranial—Mitoxantrone—multiple sclerosis	0.0109	0.043	CcSEcCtD
Tirofiban—ITGB3—Serotonin Transporter Activity—IL1B—multiple sclerosis	0.0109	0.0146	CbGpPWpGaD
Tirofiban—ITGB3—Platelet degranulation—PLEK—multiple sclerosis	0.0108	0.0145	CbGpPWpGaD
Tirofiban—ITGB3—Response to elevated platelet cytosolic Ca2+—PLEK—multiple sclerosis	0.0103	0.0138	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—CD24—multiple sclerosis	0.00982	0.0132	CbGpPWpGaD
Tirofiban—ITGB3—Osteopontin Signaling—MMP9—multiple sclerosis	0.00896	0.012	CbGpPWpGaD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—S1PR1—multiple sclerosis	0.00875	0.0117	CbGpPWpGaD
Tirofiban—ITGB3—Osteopontin-mediated events—SPP1—multiple sclerosis	0.0084	0.0113	CbGpPWpGaD
Tirofiban—ITGA2B—Beta3 integrin cell surface interactions—SPP1—multiple sclerosis	0.00839	0.0113	CbGpPWpGaD
Tirofiban—ITGA2B—Integrin cell surface interactions—ITGA4—multiple sclerosis	0.00836	0.0112	CbGpPWpGaD
Tirofiban—ITGB3—MFAP5-mediated ovarian cancer cell motility and invasiveness—MAPK1—multiple sclerosis	0.00772	0.0103	CbGpPWpGaD
Tirofiban—ITGA2B—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGA4—multiple sclerosis	0.00763	0.0102	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—CD24—multiple sclerosis	0.00756	0.0101	CbGpPWpGaD
Tirofiban—ITGA2B—Integrin cell surface interactions—VCAM1—multiple sclerosis	0.00727	0.00975	CbGpPWpGaD
Tirofiban—ITGB3—Osteopontin Signaling—MAPK1—multiple sclerosis	0.00724	0.00971	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—CD24—multiple sclerosis	0.00701	0.00939	CbGpPWpGaD
Tirofiban—Haemoglobin decreased—Mitoxantrone—multiple sclerosis	0.00651	0.0256	CcSEcCtD
Tirofiban—ITGB3—Beta3 integrin cell surface interactions—SPP1—multiple sclerosis	0.00647	0.00867	CbGpPWpGaD
Tirofiban—ITGB3—Integrin cell surface interactions—ITGA4—multiple sclerosis	0.00644	0.00864	CbGpPWpGaD
Tirofiban—ITGB3—Cell surface interactions at the vascular wall—SELE—multiple sclerosis	0.00644	0.00864	CbGpPWpGaD
Tirofiban—ITGA2B—Signal transduction by L1—MAPK1—multiple sclerosis	0.0064	0.00859	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	0.00624	0.00837	CbGpPWpGaD
Tirofiban—Bradycardia—Fingolimod—multiple sclerosis	0.00615	0.0242	CcSEcCtD
Tirofiban—ITGA2B—Integrin-mediated Cell Adhesion—ITGA4—multiple sclerosis	0.006	0.00804	CbGpPWpGaD
Tirofiban—ITGA2B—Integrin cell surface interactions—SPP1—multiple sclerosis	0.00596	0.00799	CbGpPWpGaD
Tirofiban—ITGB3—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGA4—multiple sclerosis	0.00588	0.00788	CbGpPWpGaD
Tirofiban—Swelling—Cladribine—multiple sclerosis	0.00561	0.0221	CcSEcCtD
Tirofiban—ITGB3—Integrin cell surface interactions—VCAM1—multiple sclerosis	0.0056	0.00751	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—CD24—multiple sclerosis	0.0054	0.00724	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—FOXP3—multiple sclerosis	0.0053	0.0071	CbGpPWpGaD
Tirofiban—ITGB3—Syndecan interactions—TGFB1—multiple sclerosis	0.00523	0.00701	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—MERTK—multiple sclerosis	0.00521	0.00698	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—CD58—multiple sclerosis	0.00521	0.00698	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—SELPLG—multiple sclerosis	0.00521	0.00698	CbGpPWpGaD
Tirofiban—ITGB3—IL4-mediated signaling events—IL10—multiple sclerosis	0.00519	0.00696	CbGpPWpGaD
Tirofiban—ITGB3—IL4-mediated signaling events—CD40LG—multiple sclerosis	0.00519	0.00696	CbGpPWpGaD
Tirofiban—ITGB3—IL4-mediated signaling events—IL4—multiple sclerosis	0.00505	0.00677	CbGpPWpGaD
Tirofiban—ITGA2B—Hematopoietic Stem Cell Differentiation—IL1B—multiple sclerosis	0.00502	0.00673	CbGpPWpGaD
Tirofiban—ITGA2B—Integrin cell surface interactions—ICAM1—multiple sclerosis	0.00495	0.00664	CbGpPWpGaD
Tirofiban—ITGB3—Signal transduction by L1—MAPK1—multiple sclerosis	0.00493	0.00661	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling events mediated by PTP1B—TYK2—multiple sclerosis	0.00487	0.00653	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	0.00481	0.00645	CbGpPWpGaD
Tirofiban—ITGB3—Integrins in angiogenesis—SPP1—multiple sclerosis	0.00476	0.00639	CbGpPWpGaD
Tirofiban—ITGB3—Cell surface interactions at the vascular wall—ITGA4—multiple sclerosis	0.00466	0.00624	CbGpPWpGaD
Tirofiban—ITGB3—Monoamine Transport—IL1B—multiple sclerosis	0.00462	0.0062	CbGpPWpGaD
Tirofiban—ITGB3—Integrin-mediated Cell Adhesion—ITGA4—multiple sclerosis	0.00462	0.00619	CbGpPWpGaD
Tirofiban—ITGB3—Integrin cell surface interactions—SPP1—multiple sclerosis	0.00459	0.00615	CbGpPWpGaD
Tirofiban—Hypertension—Fingolimod—multiple sclerosis	0.00454	0.0179	CcSEcCtD
Tirofiban—ITGB3—Osteopontin-mediated events—MMP9—multiple sclerosis	0.00447	0.00599	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—MERTK—multiple sclerosis	0.00401	0.00538	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—CD58—multiple sclerosis	0.00401	0.00538	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—SELPLG—multiple sclerosis	0.00401	0.00538	CbGpPWpGaD
Tirofiban—ITGB3—Hematopoietic Stem Cell Differentiation—IL1B—multiple sclerosis	0.00387	0.00518	CbGpPWpGaD
Tirofiban—ITGB3—Integrin cell surface interactions—ICAM1—multiple sclerosis	0.00382	0.00512	CbGpPWpGaD
Tirofiban—ITGB3—Molecules associated with elastic fibres—TGFB1—multiple sclerosis	0.00378	0.00507	CbGpPWpGaD
Tirofiban—ITGB3—Signaling events mediated by PTP1B—TYK2—multiple sclerosis	0.00375	0.00503	CbGpPWpGaD
Tirofiban—ITGB3—Primary Focal Segmental Glomerulosclerosis FSGS—TLR4—multiple sclerosis	0.00371	0.00498	CbGpPWpGaD
Tirofiban—Swelling—Mitoxantrone—multiple sclerosis	0.00369	0.0145	CcSEcCtD
Tirofiban—ITGB3—Osteopontin-mediated events—MAPK1—multiple sclerosis	0.00361	0.00484	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—ITGA4—multiple sclerosis	0.00359	0.00481	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet degranulation—ALB—multiple sclerosis	0.00354	0.00475	CbGpPWpGaD
Tirofiban—ITGB3—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—multiple sclerosis	0.0035	0.0047	CbGpPWpGaD
Tirofiban—Haemoglobin—Cladribine—multiple sclerosis	0.00344	0.0135	CcSEcCtD
Tirofiban—ITGB3—Primary Focal Segmental Glomerulosclerosis FSGS—CD80—multiple sclerosis	0.00343	0.00459	CbGpPWpGaD
Tirofiban—Haemorrhage—Cladribine—multiple sclerosis	0.00342	0.0135	CcSEcCtD
Tirofiban—ITGA2B—Signaling events mediated by PTP1B—STAT3—multiple sclerosis	0.00341	0.00457	CbGpPWpGaD
Tirofiban—ITGA2B—Response to elevated platelet cytosolic Ca2+—ALB—multiple sclerosis	0.00337	0.00452	CbGpPWpGaD
Tirofiban—ITGB3—Monoamine Transport—TNF—multiple sclerosis	0.00335	0.0045	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—PRNP—multiple sclerosis	0.00324	0.00434	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—PLEK—multiple sclerosis	0.00322	0.00431	CbGpPWpGaD
Tirofiban—Haematemesis—Methotrexate—multiple sclerosis	0.00321	0.0126	CcSEcCtD
Tirofiban—Chills—Cladribine—multiple sclerosis	0.00307	0.0121	CcSEcCtD
Tirofiban—ITGA2B—ECM proteoglycans—TGFB1—multiple sclerosis	0.00302	0.00405	CbGpPWpGaD
Tirofiban—ITGB3—Elastic fibre formation—TGFB1—multiple sclerosis	0.00294	0.00395	CbGpPWpGaD
Tirofiban—ITGA2B—Hematopoietic Stem Cell Differentiation—IL6—multiple sclerosis	0.00294	0.00394	CbGpPWpGaD
Tirofiban—ITGB3—Non-integrin membrane-ECM interactions—TGFB1—multiple sclerosis	0.00289	0.00387	CbGpPWpGaD
Tirofiban—ITGB3—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—multiple sclerosis	0.00289	0.00387	CbGpPWpGaD
Tirofiban—Dizziness—Fingolimod—multiple sclerosis	0.00284	0.0112	CcSEcCtD
Tirofiban—Hypercholesterolaemia—Prednisone—multiple sclerosis	0.00283	0.0111	CcSEcCtD
Tirofiban—Haemoglobin—Azathioprine—multiple sclerosis	0.0028	0.011	CcSEcCtD
Tirofiban—Haemorrhage—Azathioprine—multiple sclerosis	0.00278	0.011	CcSEcCtD
Tirofiban—ITGB3—Focal Adhesion—ITGA4—multiple sclerosis	0.00276	0.00371	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—ITGA4—multiple sclerosis	0.00276	0.0037	CbGpPWpGaD
Tirofiban—ITGB3—Platelet degranulation—ALB—multiple sclerosis	0.00273	0.00366	CbGpPWpGaD
Tirofiban—Headache—Fingolimod—multiple sclerosis	0.00269	0.0106	CcSEcCtD
Tirofiban—ITGB3—Signaling events mediated by PTP1B—STAT3—multiple sclerosis	0.00263	0.00352	CbGpPWpGaD
Tirofiban—ITGB3—Response to elevated platelet cytosolic Ca2+—ALB—multiple sclerosis	0.0026	0.00348	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—SPP1—multiple sclerosis	0.00256	0.00343	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—PTPRC—multiple sclerosis	0.00252	0.00338	CbGpPWpGaD
Tirofiban—Chills—Azathioprine—multiple sclerosis	0.0025	0.00983	CcSEcCtD
Tirofiban—ITGB3—Axon guidance—PRNP—multiple sclerosis	0.00249	0.00335	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—PLEK—multiple sclerosis	0.00248	0.00332	CbGpPWpGaD
Tirofiban—Myocardial infarction—Mitoxantrone—multiple sclerosis	0.00246	0.00967	CcSEcCtD
Tirofiban—Oedema—Cladribine—multiple sclerosis	0.00243	0.00957	CcSEcCtD
Tirofiban—Sweating—Mitoxantrone—multiple sclerosis	0.0024	0.00945	CcSEcCtD
Tirofiban—ITGA2B—Extracellular matrix organization—VCAM1—multiple sclerosis	0.0024	0.00322	CbGpPWpGaD
Tirofiban—Haematuria—Mitoxantrone—multiple sclerosis	0.00239	0.0094	CcSEcCtD
Tirofiban—Thrombocytopenia—Cladribine—multiple sclerosis	0.00238	0.00937	CcSEcCtD
Tirofiban—Hyperhidrosis—Cladribine—multiple sclerosis	0.00235	0.00925	CcSEcCtD
Tirofiban—ITGB3—ECM proteoglycans—TGFB1—multiple sclerosis	0.00233	0.00312	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—PRNP—multiple sclerosis	0.00231	0.0031	CbGpPWpGaD
Tirofiban—Bradycardia—Mitoxantrone—multiple sclerosis	0.00229	0.00901	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—SELE—multiple sclerosis	0.00227	0.00304	CbGpPWpGaD
Tirofiban—ITGB3—Hematopoietic Stem Cell Differentiation—IL6—multiple sclerosis	0.00226	0.00303	CbGpPWpGaD
Tirofiban—Haemoglobin—Mitoxantrone—multiple sclerosis	0.00226	0.0089	CcSEcCtD
Tirofiban—Haemorrhage—Mitoxantrone—multiple sclerosis	0.00225	0.00885	CcSEcCtD
Tirofiban—ITGA2B—Platelet degranulation—TGFB1—multiple sclerosis	0.00224	0.003	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	0.00217	0.00291	CbGpPWpGaD
Tirofiban—ITGA2B—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	0.00213	0.00286	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—ITGA4—multiple sclerosis	0.00212	0.00285	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—TYK2—multiple sclerosis	0.00211	0.00282	CbGpPWpGaD
Tirofiban—Pain—Cladribine—multiple sclerosis	0.00208	0.00818	CcSEcCtD
Tirofiban—ITGB3—Integrins in angiogenesis—MAPK1—multiple sclerosis	0.00205	0.00275	CbGpPWpGaD
Tirofiban—Chills—Mitoxantrone—multiple sclerosis	0.00202	0.00794	CcSEcCtD
Tirofiban—Myocardial infarction—Prednisolone—multiple sclerosis	0.00202	0.00793	CcSEcCtD
Tirofiban—ITGB3—Signaling by VEGF—TYK2—multiple sclerosis	0.00199	0.00267	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—SPP1—multiple sclerosis	0.00197	0.00264	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—SPP1—multiple sclerosis	0.00197	0.00264	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—PTPRC—multiple sclerosis	0.00194	0.0026	CbGpPWpGaD
Tirofiban—Thrombocytopenia—Azathioprine—multiple sclerosis	0.00194	0.00762	CcSEcCtD
Tirofiban—Urticaria—Cladribine—multiple sclerosis	0.00193	0.0076	CcSEcCtD
Tirofiban—ITGB3—Signaling events mediated by VEGFR1 and VEGFR2—MAPK1—multiple sclerosis	0.00193	0.00258	CbGpPWpGaD
Tirofiban—Body temperature increased—Cladribine—multiple sclerosis	0.00192	0.00756	CcSEcCtD
Tirofiban—ITGA2B—L1CAM interactions—MAPK1—multiple sclerosis	0.0019	0.00255	CbGpPWpGaD
Tirofiban—Bradycardia—Prednisolone—multiple sclerosis	0.00188	0.00739	CcSEcCtD
Tirofiban—ITGB3—Primary Focal Segmental Glomerulosclerosis FSGS—TGFB1—multiple sclerosis	0.00188	0.00252	CbGpPWpGaD
Tirofiban—Haemoglobin—Prednisolone—multiple sclerosis	0.00186	0.0073	CcSEcCtD
Tirofiban—Myocardial infarction—Triamcinolone—multiple sclerosis	0.00185	0.00729	CcSEcCtD
Tirofiban—Myocardial infarction—Methylprednisolone—multiple sclerosis	0.00185	0.00728	CcSEcCtD
Tirofiban—ITGB3—Extracellular matrix organization—VCAM1—multiple sclerosis	0.00185	0.00248	CbGpPWpGaD
Tirofiban—Haemorrhage—Prednisolone—multiple sclerosis	0.00185	0.00726	CcSEcCtD
Tirofiban—ITGA2B—Integrin-mediated Cell Adhesion—MAPK1—multiple sclerosis	0.00184	0.00246	CbGpPWpGaD
Tirofiban—Sweating—Methylprednisolone—multiple sclerosis	0.00181	0.00712	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—PTPRC—multiple sclerosis	0.0018	0.00241	CbGpPWpGaD
Tirofiban—Hypersensitivity—Cladribine—multiple sclerosis	0.00179	0.00705	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—PRNP—multiple sclerosis	0.00178	0.00239	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—SELE—multiple sclerosis	0.00175	0.00234	CbGpPWpGaD
Tirofiban—Bradycardia—Triamcinolone—multiple sclerosis	0.00173	0.0068	CcSEcCtD
Tirofiban—ITGB3—Platelet degranulation—TGFB1—multiple sclerosis	0.00173	0.00231	CbGpPWpGaD
Tirofiban—Bradycardia—Methylprednisolone—multiple sclerosis	0.00172	0.00678	CcSEcCtD
Tirofiban—Haemoglobin—Triamcinolone—multiple sclerosis	0.00171	0.00671	CcSEcCtD
Tirofiban—Haemoglobin—Methylprednisolone—multiple sclerosis	0.0017	0.0067	CcSEcCtD
Tirofiban—Haemorrhage—Triamcinolone—multiple sclerosis	0.0017	0.00668	CcSEcCtD
Tirofiban—Haemorrhage—Methylprednisolone—multiple sclerosis	0.00169	0.00666	CcSEcCtD
Tirofiban—Hypertension—Mitoxantrone—multiple sclerosis	0.00169	0.00665	CcSEcCtD
Tirofiban—Myocardial infarction—Dexamethasone—multiple sclerosis	0.00168	0.00662	CcSEcCtD
Tirofiban—Myocardial infarction—Betamethasone—multiple sclerosis	0.00168	0.00662	CcSEcCtD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	0.00167	0.00224	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—LINGO1—multiple sclerosis	0.00166	0.00223	CbGpPWpGaD
Tirofiban—ITGB3—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	0.00164	0.0022	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—ITGA4—multiple sclerosis	0.00164	0.0022	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—ICAM1—multiple sclerosis	0.00163	0.00219	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—IFNB1—multiple sclerosis	0.00163	0.00218	CbGpPWpGaD
Tirofiban—Dizziness—Cladribine—multiple sclerosis	0.00161	0.00633	CcSEcCtD
Tirofiban—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.0016	0.00629	CcSEcCtD
Tirofiban—Oedema—Mitoxantrone—multiple sclerosis	0.0016	0.00629	CcSEcCtD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	0.00157	0.00211	CbGpPWpGaD
Tirofiban—Bradycardia—Dexamethasone—multiple sclerosis	0.00157	0.00617	CcSEcCtD
Tirofiban—Bradycardia—Betamethasone—multiple sclerosis	0.00157	0.00617	CcSEcCtD
Tirofiban—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.00157	0.00616	CcSEcCtD
Tirofiban—Body temperature increased—Azathioprine—multiple sclerosis	0.00156	0.00615	CcSEcCtD
Tirofiban—Haemoglobin—Dexamethasone—multiple sclerosis	0.00155	0.00609	CcSEcCtD
Tirofiban—Haemoglobin—Betamethasone—multiple sclerosis	0.00155	0.00609	CcSEcCtD
Tirofiban—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.00155	0.00608	CcSEcCtD
Tirofiban—Haemorrhage—Betamethasone—multiple sclerosis	0.00154	0.00606	CcSEcCtD
Tirofiban—Haemorrhage—Dexamethasone—multiple sclerosis	0.00154	0.00606	CcSEcCtD
Tirofiban—Headache—Cladribine—multiple sclerosis	0.00152	0.00599	CcSEcCtD
Tirofiban—ITGB3—Extracellular matrix organization—SPP1—multiple sclerosis	0.00151	0.00203	CbGpPWpGaD
Tirofiban—Myocardial infarction—Prednisone—multiple sclerosis	0.00147	0.00576	CcSEcCtD
Tirofiban—ITGB3—L1CAM interactions—MAPK1—multiple sclerosis	0.00146	0.00196	CbGpPWpGaD
Tirofiban—Hypersensitivity—Azathioprine—multiple sclerosis	0.00146	0.00573	CcSEcCtD
Tirofiban—Nausea—Cladribine—multiple sclerosis	0.00145	0.00568	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—TAGAP—multiple sclerosis	0.00144	0.00193	CbGpPWpGaD
Tirofiban—ITGB3—Integrin-mediated Cell Adhesion—MAPK1—multiple sclerosis	0.00142	0.0019	CbGpPWpGaD
Tirofiban—Hypertension—Prednisolone—multiple sclerosis	0.00139	0.00546	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—PTPRC—multiple sclerosis	0.00138	0.00186	CbGpPWpGaD
Tirofiban—Pain—Mitoxantrone—multiple sclerosis	0.00137	0.00538	CcSEcCtD
Tirofiban—Bradycardia—Prednisone—multiple sclerosis	0.00137	0.00537	CcSEcCtD
Tirofiban—Haemoglobin—Prednisone—multiple sclerosis	0.00135	0.0053	CcSEcCtD
Tirofiban—Haemorrhage—Prednisone—multiple sclerosis	0.00134	0.00528	CcSEcCtD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—MAPK1—multiple sclerosis	0.00134	0.0018	CbGpPWpGaD
Tirofiban—Oedema—Prednisolone—multiple sclerosis	0.00131	0.00516	CcSEcCtD
Tirofiban—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00131	0.00516	CcSEcCtD
Tirofiban—Dizziness—Azathioprine—multiple sclerosis	0.00131	0.00515	CcSEcCtD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—STAT3—multiple sclerosis	0.0013	0.00175	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—LINGO1—multiple sclerosis	0.00128	0.00171	CbGpPWpGaD
Tirofiban—Hypertension—Triamcinolone—multiple sclerosis	0.00128	0.00502	CcSEcCtD
Tirofiban—Hypertension—Methylprednisolone—multiple sclerosis	0.00127	0.00501	CcSEcCtD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	0.00127	0.00171	CbGpPWpGaD
Tirofiban—Urticaria—Mitoxantrone—multiple sclerosis	0.00127	0.005	CcSEcCtD
Tirofiban—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00127	0.00499	CcSEcCtD
Tirofiban—ITGB3—Signaling by VEGF—MAPK1—multiple sclerosis	0.00127	0.0017	CbGpPWpGaD
Tirofiban—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00126	0.00497	CcSEcCtD
Tirofiban—ITGB3—Hemostasis—ITGA4—multiple sclerosis	0.00126	0.00169	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—ICAM1—multiple sclerosis	0.00126	0.00169	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—S1PR1—multiple sclerosis	0.00126	0.00169	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—IFNB1—multiple sclerosis	0.00125	0.00168	CbGpPWpGaD
Tirofiban—Headache—Azathioprine—multiple sclerosis	0.00124	0.00487	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—GPC5—multiple sclerosis	0.00122	0.00164	CbGpPWpGaD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—MYC—multiple sclerosis	0.00121	0.00162	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	0.00121	0.00162	CbGpPWpGaD
Tirofiban—Oedema—Triamcinolone—multiple sclerosis	0.00121	0.00475	CcSEcCtD
Tirofiban—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00121	0.00475	CcSEcCtD
Tirofiban—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.0012	0.00473	CcSEcCtD
Tirofiban—Sweating—Methotrexate—multiple sclerosis	0.0012	0.00471	CcSEcCtD
Tirofiban—Haematuria—Methotrexate—multiple sclerosis	0.00119	0.00469	CcSEcCtD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—MAPK1—multiple sclerosis	0.00118	0.00159	CbGpPWpGaD
Tirofiban—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00118	0.00463	CcSEcCtD
Tirofiban—Nausea—Azathioprine—multiple sclerosis	0.00118	0.00462	CcSEcCtD
Tirofiban—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00117	0.00459	CcSEcCtD
Tirofiban—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.00116	0.00458	CcSEcCtD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—MYC—multiple sclerosis	0.00116	0.00155	CbGpPWpGaD
Tirofiban—Hypertension—Betamethasone—multiple sclerosis	0.00116	0.00456	CcSEcCtD
Tirofiban—Hypertension—Dexamethasone—multiple sclerosis	0.00116	0.00456	CcSEcCtD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—TGFB1—multiple sclerosis	0.00116	0.00155	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—MAPK1—multiple sclerosis	0.00113	0.00152	CbGpPWpGaD
Tirofiban—Haemoglobin—Methotrexate—multiple sclerosis	0.00113	0.00443	CcSEcCtD
Tirofiban—ITGA2B—Axon guidance—TYK2—multiple sclerosis	0.00113	0.00151	CbGpPWpGaD
Tirofiban—Pain—Prednisolone—multiple sclerosis	0.00112	0.00441	CcSEcCtD
Tirofiban—Haemorrhage—Methotrexate—multiple sclerosis	0.00112	0.00441	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—IL2RA—multiple sclerosis	0.00112	0.0015	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TAGAP—multiple sclerosis	0.00111	0.00149	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—MAPK1—multiple sclerosis	0.0011	0.00147	CbGpPWpGaD
Tirofiban—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00109	0.00431	CcSEcCtD
Tirofiban—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00109	0.00431	CcSEcCtD
Tirofiban—Oedema—Betamethasone—multiple sclerosis	0.00109	0.00431	CcSEcCtD
Tirofiban—Oedema—Dexamethasone—multiple sclerosis	0.00109	0.00431	CcSEcCtD
Tirofiban—Thrombocytopenia—Betamethasone—multiple sclerosis	0.00107	0.00422	CcSEcCtD
Tirofiban—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.00107	0.00422	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—RGS1—multiple sclerosis	0.00107	0.00143	CbGpPWpGaD
Tirofiban—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00106	0.00416	CcSEcCtD
Tirofiban—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00106	0.00416	CcSEcCtD
Tirofiban—ITGA2B—Extracellular matrix organization—MMP9—multiple sclerosis	0.00105	0.0014	CbGpPWpGaD
Tirofiban—Urticaria—Prednisolone—multiple sclerosis	0.00104	0.0041	CcSEcCtD
Tirofiban—Pain—Triamcinolone—multiple sclerosis	0.00103	0.00406	CcSEcCtD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—IL6—multiple sclerosis	0.00103	0.00138	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—GPR65—multiple sclerosis	0.00101	0.00136	CbGpPWpGaD
Tirofiban—Hypertension—Prednisone—multiple sclerosis	0.00101	0.00397	CcSEcCtD
Tirofiban—Chills—Methotrexate—multiple sclerosis	0.00101	0.00396	CcSEcCtD
Tirofiban—Headache—Mitoxantrone—multiple sclerosis	0.001	0.00394	CcSEcCtD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	0.000993	0.00133	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	0.000981	0.00132	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	0.000974	0.00131	CbGpPWpGaD
Tirofiban—ITGB3—Signaling by VEGF—IL6—multiple sclerosis	0.000972	0.0013	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—S1PR1—multiple sclerosis	0.000969	0.0013	CbGpPWpGaD
Tirofiban—Hypersensitivity—Prednisolone—multiple sclerosis	0.000967	0.0038	CcSEcCtD
Tirofiban—Urticaria—Triamcinolone—multiple sclerosis	0.000958	0.00377	CcSEcCtD
Tirofiban—Urticaria—Methylprednisolone—multiple sclerosis	0.000956	0.00376	CcSEcCtD
Tirofiban—Body temperature increased—Triamcinolone—multiple sclerosis	0.000954	0.00375	CcSEcCtD
Tirofiban—Anaphylactic shock—Prednisone—multiple sclerosis	0.000953	0.00375	CcSEcCtD
Tirofiban—Oedema—Prednisone—multiple sclerosis	0.000953	0.00375	CcSEcCtD
Tirofiban—Nausea—Mitoxantrone—multiple sclerosis	0.00095	0.00374	CcSEcCtD
Tirofiban—ITGB3—Signaling Pathways—GPC5—multiple sclerosis	0.000943	0.00126	CbGpPWpGaD
Tirofiban—Pain—Dexamethasone—multiple sclerosis	0.000936	0.00368	CcSEcCtD
Tirofiban—Pain—Betamethasone—multiple sclerosis	0.000936	0.00368	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—CCR1—multiple sclerosis	0.000928	0.00124	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CXCL13—multiple sclerosis	0.000928	0.00124	CbGpPWpGaD
Tirofiban—Hyperhidrosis—Prednisone—multiple sclerosis	0.000922	0.00363	CcSEcCtD
Tirofiban—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000889	0.0035	CcSEcCtD
Tirofiban—ITGA2B—Axon guidance—MMP9—multiple sclerosis	0.000887	0.00119	CbGpPWpGaD
Tirofiban—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000887	0.00349	CcSEcCtD
Tirofiban—Urticaria—Dexamethasone—multiple sclerosis	0.00087	0.00342	CcSEcCtD
Tirofiban—Urticaria—Betamethasone—multiple sclerosis	0.00087	0.00342	CcSEcCtD
Tirofiban—ITGB3—Axon guidance—TYK2—multiple sclerosis	0.000868	0.00116	CbGpPWpGaD
Tirofiban—Dizziness—Prednisolone—multiple sclerosis	0.000868	0.00341	CcSEcCtD
Tirofiban—Body temperature increased—Dexamethasone—multiple sclerosis	0.000865	0.0034	CcSEcCtD
Tirofiban—Body temperature increased—Betamethasone—multiple sclerosis	0.000865	0.0034	CcSEcCtD
Tirofiban—ITGB3—Hemostasis—IL2RA—multiple sclerosis	0.000863	0.00116	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—TGFB1—multiple sclerosis	0.000862	0.00116	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—MAPK1—multiple sclerosis	0.000847	0.00114	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—RGS1—multiple sclerosis	0.000824	0.00111	CbGpPWpGaD
Tirofiban—Headache—Prednisolone—multiple sclerosis	0.000822	0.00323	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—ALB—multiple sclerosis	0.00081	0.00109	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—MMP9—multiple sclerosis	0.000805	0.00108	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—TYK2—multiple sclerosis	0.000804	0.00108	CbGpPWpGaD
Tirofiban—Dizziness—Triamcinolone—multiple sclerosis	0.000798	0.00314	CcSEcCtD
Tirofiban—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000797	0.00313	CcSEcCtD
Tirofiban—Dizziness—Methylprednisolone—multiple sclerosis	0.000796	0.00313	CcSEcCtD
Tirofiban—ITGB3—Signaling Pathways—GPR65—multiple sclerosis	0.000781	0.00105	CbGpPWpGaD
Tirofiban—Thrombocytopenia—Methotrexate—multiple sclerosis	0.00078	0.00307	CcSEcCtD
Tirofiban—Nausea—Prednisolone—multiple sclerosis	0.000779	0.00307	CcSEcCtD
Tirofiban—Hyperhidrosis—Methotrexate—multiple sclerosis	0.00077	0.00303	CcSEcCtD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	0.000765	0.00103	CbGpPWpGaD
Tirofiban—Urticaria—Prednisone—multiple sclerosis	0.000757	0.00298	CcSEcCtD
Tirofiban—Headache—Triamcinolone—multiple sclerosis	0.000756	0.00297	CcSEcCtD
Tirofiban—Headache—Methylprednisolone—multiple sclerosis	0.000754	0.00297	CcSEcCtD
Tirofiban—Body temperature increased—Prednisone—multiple sclerosis	0.000754	0.00296	CcSEcCtD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	0.00075	0.00101	CbGpPWpGaD
Tirofiban—Dizziness—Dexamethasone—multiple sclerosis	0.000724	0.00285	CcSEcCtD
Tirofiban—Dizziness—Betamethasone—multiple sclerosis	0.000724	0.00285	CcSEcCtD
Tirofiban—ITGA2B—Axon guidance—MAPK1—multiple sclerosis	0.000717	0.000962	CbGpPWpGaD
Tirofiban—Nausea—Triamcinolone—multiple sclerosis	0.000717	0.00282	CcSEcCtD
Tirofiban—Nausea—Methylprednisolone—multiple sclerosis	0.000715	0.00281	CcSEcCtD
Tirofiban—ITGB3—Signaling Pathways—CCR1—multiple sclerosis	0.000715	0.000958	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CXCL13—multiple sclerosis	0.000715	0.000958	CbGpPWpGaD
Tirofiban—Hypersensitivity—Prednisone—multiple sclerosis	0.000702	0.00276	CcSEcCtD
Tirofiban—Headache—Betamethasone—multiple sclerosis	0.000686	0.0027	CcSEcCtD
Tirofiban—Headache—Dexamethasone—multiple sclerosis	0.000686	0.0027	CcSEcCtD
Tirofiban—ITGB3—Axon guidance—MMP9—multiple sclerosis	0.000684	0.000917	CbGpPWpGaD
Tirofiban—Pain—Methotrexate—multiple sclerosis	0.000681	0.00268	CcSEcCtD
Tirofiban—ITGB3—Extracellular matrix organization—TGFB1—multiple sclerosis	0.000664	0.00089	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CCL3—multiple sclerosis	0.000661	0.000886	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—IL2—multiple sclerosis	0.000656	0.00088	CbGpPWpGaD
Tirofiban—Nausea—Betamethasone—multiple sclerosis	0.00065	0.00256	CcSEcCtD
Tirofiban—Nausea—Dexamethasone—multiple sclerosis	0.00065	0.00256	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—PTGER4—multiple sclerosis	0.000636	0.000853	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—MMP9—multiple sclerosis	0.000633	0.000849	CbGpPWpGaD
Tirofiban—Urticaria—Methotrexate—multiple sclerosis	0.000633	0.00249	CcSEcCtD
Tirofiban—Dizziness—Prednisone—multiple sclerosis	0.00063	0.00248	CcSEcCtD
Tirofiban—Body temperature increased—Methotrexate—multiple sclerosis	0.00063	0.00248	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—PGR—multiple sclerosis	0.000627	0.00084	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—ALB—multiple sclerosis	0.000624	0.000836	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—TYK2—multiple sclerosis	0.000619	0.000831	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CXCR3—multiple sclerosis	0.000614	0.000824	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CD28—multiple sclerosis	0.000609	0.000816	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CCR2—multiple sclerosis	0.000598	0.000801	CbGpPWpGaD
Tirofiban—Headache—Prednisone—multiple sclerosis	0.000597	0.00235	CcSEcCtD
Tirofiban—Hypersensitivity—Methotrexate—multiple sclerosis	0.000587	0.00231	CcSEcCtD
Tirofiban—Nausea—Prednisone—multiple sclerosis	0.000566	0.00223	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—STAT3—multiple sclerosis	0.000563	0.000755	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—MAPK1—multiple sclerosis	0.000553	0.000741	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CNR1—multiple sclerosis	0.000552	0.00074	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—IL6—multiple sclerosis	0.000551	0.000739	CbGpPWpGaD
Tirofiban—Dizziness—Methotrexate—multiple sclerosis	0.000527	0.00207	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—TGFB1—multiple sclerosis	0.000522	0.0007	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—TGFB1—multiple sclerosis	0.000512	0.000687	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—MAPK1—multiple sclerosis	0.000512	0.000686	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CCL3—multiple sclerosis	0.000509	0.000683	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—IL2—multiple sclerosis	0.000506	0.000678	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—MAPK1—multiple sclerosis	0.000502	0.000673	CbGpPWpGaD
Tirofiban—Headache—Methotrexate—multiple sclerosis	0.000499	0.00196	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—CXCL10—multiple sclerosis	0.000497	0.000666	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PTGER4—multiple sclerosis	0.00049	0.000657	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—MMP9—multiple sclerosis	0.000488	0.000654	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—TNF—multiple sclerosis	0.000487	0.000654	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PGR—multiple sclerosis	0.000483	0.000647	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CXCR3—multiple sclerosis	0.000473	0.000635	CbGpPWpGaD
Tirofiban—Nausea—Methotrexate—multiple sclerosis	0.000473	0.00186	CcSEcCtD
Tirofiban—ITGB3—Signaling Pathways—CD28—multiple sclerosis	0.000469	0.000629	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CCR2—multiple sclerosis	0.00046	0.000617	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CD86—multiple sclerosis	0.000434	0.000582	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—STAT3—multiple sclerosis	0.000434	0.000582	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CCL5—multiple sclerosis	0.000428	0.000573	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CNR1—multiple sclerosis	0.000425	0.00057	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—IL6—multiple sclerosis	0.000425	0.000569	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—TGFB1—multiple sclerosis	0.000402	0.000539	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—SPP1—multiple sclerosis	0.000396	0.000531	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—TGFB1—multiple sclerosis	0.000394	0.000529	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—MAPK1—multiple sclerosis	0.000394	0.000529	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—IL6—multiple sclerosis	0.000393	0.000527	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—MAPK1—multiple sclerosis	0.000387	0.000519	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CCR5—multiple sclerosis	0.000385	0.000516	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CXCL10—multiple sclerosis	0.000383	0.000513	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IL2RA—multiple sclerosis	0.00038	0.000509	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—TNF—multiple sclerosis	0.000375	0.000503	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—APOE—multiple sclerosis	0.00035	0.00047	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CD86—multiple sclerosis	0.000335	0.000449	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CCL5—multiple sclerosis	0.000329	0.000442	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CD80—multiple sclerosis	0.000317	0.000425	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—SPP1—multiple sclerosis	0.000305	0.000409	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—IL6—multiple sclerosis	0.000303	0.000406	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—POMC—multiple sclerosis	0.000301	0.000404	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CCR5—multiple sclerosis	0.000297	0.000398	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CCL2—multiple sclerosis	0.000295	0.000395	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IL2RA—multiple sclerosis	0.000292	0.000392	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—APOE—multiple sclerosis	0.00027	0.000362	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TYK2—multiple sclerosis	0.000267	0.000359	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CD80—multiple sclerosis	0.000244	0.000327	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—POMC—multiple sclerosis	0.000232	0.000311	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CCL2—multiple sclerosis	0.000227	0.000304	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IL2—multiple sclerosis	0.000223	0.000298	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MMP9—multiple sclerosis	0.000211	0.000282	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TYK2—multiple sclerosis	0.000206	0.000276	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—STAT3—multiple sclerosis	0.000187	0.000251	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MYC—multiple sclerosis	0.000174	0.000233	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TGFB1—multiple sclerosis	0.000174	0.000233	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IL2—multiple sclerosis	0.000171	0.00023	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MAPK1—multiple sclerosis	0.00017	0.000228	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MMP9—multiple sclerosis	0.000162	0.000218	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—STAT3—multiple sclerosis	0.000144	0.000193	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MYC—multiple sclerosis	0.000134	0.00018	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TGFB1—multiple sclerosis	0.000134	0.000179	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MAPK1—multiple sclerosis	0.000131	0.000176	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IL6—multiple sclerosis	0.000131	0.000175	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IL6—multiple sclerosis	0.000101	0.000135	CbGpPWpGaD
